Outsourcing and Vendor Management

Measuring eTMF Compliance and Timeliness

Posted on digi By digi

The Trial Master File (TMF), including its electronic version (eTMF), is the cornerstone of regulatory inspections. It provides the story of how a clinical trial was conducted and whether it complied with ICH-GCP and regulatory requirements. Sponsors outsourcing trial operations to CROs remain responsible for ensuring that eTMF content is complete, accurate, and timely. Regulators frequently issue findings for incomplete or delayed TMF documentation, which directly compromises inspection readiness. eTMF compliance and timeliness KPIs therefore serve as essential tools for oversight. They quantify whether vendors are meeting obligations for document submission, indexing, and quality. This tutorial outlines the key eTMF metrics sponsors should monitor, how to configure systems to capture them, and best practices for embedding them into governance and contracts.
Click to read the full article.

KPIs for Vendor Performance, Outsourcing and Vendor Management

Vendor Performance Scorecard Templates

Posted on digi By digi

In outsourced clinical research, sponsors delegate critical responsibilities to CROs and other vendors, but regulatory frameworks such as ICH-GCP E6(R2), FDA 21 CFR Part 312, and EU CTR 536/2014 make it clear that accountability cannot be delegated. Sponsors must oversee and document vendor performance systematically. One of the most practical tools for this purpose is the vendor performance scorecard. Scorecards consolidate multiple Key Performance Indicators (KPIs) into a structured, visual format. They allow sponsors to benchmark performance, identify risks early, and make data-driven decisions regarding contract renewals or corrective actions. This tutorial explains how to design vendor performance scorecard templates, what metrics to include, and how to integrate them into governance and inspection readiness systems.
Click to read the full article.

KPIs for Vendor Performance, Outsourcing and Vendor Management

Corrective Actions Based on KPI Deviations

Posted on digi By digi

Key Performance Indicators (KPIs) are designed to provide sponsors with measurable insights into CRO and vendor performance. However, KPIs are only useful if deviations from thresholds lead to meaningful corrective and preventive actions (CAPAs). Regulatory authorities expect sponsors to not only monitor KPIs but also document responses to poor performance. Without corrective actions, KPIs risk becoming passive indicators rather than active governance tools. This article explains how KPI deviations should trigger CAPAs, explores regulatory expectations, provides real-world case studies, and offers best practices for ensuring KPI-driven CAPAs are inspection-ready and effective.
Click to read the full article.

KPIs for Vendor Performance, Outsourcing and Vendor Management

Role of Real-Time Dashboards in KPI Tracking

Posted on digi By digi

Outsourced clinical trials rely on vendors such as CROs, laboratories, and technology providers to execute critical tasks. Sponsors, however, remain accountable for compliance, data integrity, and patient safety. While Key Performance Indicators (KPIs) provide measurable oversight, their effectiveness is limited if data is delayed, fragmented, or not actionable. Real-time dashboards transform KPI tracking by consolidating metrics into visual, interactive displays accessible to sponsors and governance committees. They support proactive management, faster decision-making, and inspection readiness by ensuring oversight evidence is contemporaneous. This article explores how real-time dashboards improve KPI tracking, what metrics they should display, and how to integrate them with CTMS, eTMF, and other systems.
Click to read the full article.

KPIs for Vendor Performance, Outsourcing and Vendor Management

Linking KPIs to Incentive Payments

Posted on digi By digi

In outsourced clinical trials, Key Performance Indicators (KPIs) measure vendor performance across operational, quality, financial, and compliance domains. However, KPIs are most effective when directly linked to financial incentives and penalties. Regulators expect sponsors to demonstrate accountability for vendor oversight, while finance teams seek mechanisms to control costs and improve efficiency. Tying incentive payments to KPIs ensures CROs are not only monitored but also financially motivated to meet performance standards. This tutorial explains how to design contracts that link KPIs to payments, supported by case studies, dashboards, and best practices for regulatory compliance and inspection readiness.
Click to read the full article.

KPIs for Vendor Performance, Outsourcing and Vendor Management

Types of Audits for Clinical Trial Vendors

Posted on digi By digi

Vendors such as CROs, laboratories, and technology providers play critical roles in the conduct of outsourced clinical trials. However, sponsors remain accountable under ICH-GCP E6(R2), FDA 21 CFR Part 312, and EU CTR 536/2014 for ensuring trial quality, patient safety, and data integrity. Audits are one of the primary oversight mechanisms sponsors use to evaluate vendor compliance, identify risks, and ensure inspection readiness. Different audit types serve different purposes—ranging from prequalification to ongoing monitoring and targeted for-cause investigations. This article explains the main types of vendor audits, provides real-world examples, and offers best practices for planning, conducting, and documenting audits to satisfy regulatory expectations.
Click to read the full article.

Outsourcing and Vendor Management, Vendor Oversight and Audits

Preparing for a CRO Oversight Visit

Posted on digi By digi

While sponsors often delegate operational tasks to CROs, ultimate accountability for clinical trials remains with the sponsor. Regulators such as the FDA, EMA, and MHRA emphasize that sponsors must actively oversee CRO performance to ensure data integrity, patient safety, and regulatory compliance. One of the most effective tools for this is the CRO oversight visit. These visits allow sponsors to review CRO systems, SOPs, staff qualifications, and trial-specific performance in person. Preparing properly for an oversight visit is essential for demonstrating sponsor accountability and inspection readiness. This tutorial outlines a structured approach to preparing for CRO oversight visits, supported by examples, checklists, and case studies.
Click to read the full article.

Outsourcing and Vendor Management, Vendor Oversight and Audits

Vendor Audit SOPs and Documentation

Posted on digi By digi

Audits are critical sponsor tools for evaluating CRO and vendor compliance in outsourced clinical trials. However, audits are only defensible if they follow standardized procedures and are supported by thorough documentation. Regulatory inspectors expect sponsors to maintain Standard Operating Procedures (SOPs) governing vendor audits and to file audit documentation in the Trial Master File (TMF). Without these, sponsors risk inspection findings for inadequate oversight. This tutorial outlines how to design vendor audit SOPs, what documentation must be maintained, and how to integrate audits into governance systems for inspection readiness.
Click to read the full article.

Outsourcing and Vendor Management, Vendor Oversight and Audits

Audit Findings and CAPA Implementation

Posted on digi By digi

Audits are essential for ensuring compliance, quality, and regulatory readiness in outsourced clinical trials. However, audits alone do not improve performance unless their findings are translated into effective Corrective and Preventive Actions (CAPAs). Regulators such as FDA, EMA, and MHRA frequently scrutinize not just audit reports but also how sponsors and CROs manage findings, initiate CAPAs, and demonstrate closure. Weak or incomplete CAPA processes are among the most common inspection findings. This tutorial outlines how sponsors should manage audit findings, design CAPAs, track implementation, and document outcomes to satisfy regulatory expectations and strengthen vendor partnerships.
Click to read the full article.

Outsourcing and Vendor Management, Vendor Oversight and Audits

Virtual Vendor Audits: Tools and Techniques

Posted on digi By digi

Vendor audits are a cornerstone of sponsor oversight in outsourced clinical trials. Traditionally conducted onsite, audits have increasingly shifted to virtual formats, driven by globalization, cost pressures, and more recently, the COVID-19 pandemic. Regulatory authorities including FDA, EMA, and MHRA have accepted virtual audits as legitimate oversight tools, provided they are well-structured and documented. Virtual audits leverage technology platforms to review systems, interview staff, and examine documentation remotely. This tutorial explains the tools, techniques, case studies, and best practices that sponsors should adopt to conduct effective virtual vendor audits and ensure inspection readiness.
Click to read the full article.

Outsourcing and Vendor Management, Vendor Oversight and Audits